12 research outputs found

    Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC

    Get PDF
    To evaluate toxicity and patterns of radiologic lung injury on CT images after hypofractionated image-guided stereotactic body radiotherapy (SBRT) delivered with helical tomotherapy (HT) in medically early stage inoperable non-small-cell lung cancer (NSCLC)

    Radiotherapy for inoperable non-small cell lung cancer using helical tomotherapy

    No full text
    Aim. To investigate the impact of tomotherapy on the dose delivered to the lungs and other normal tissues. Material and methods. From February 2008 to May 2009, 35 patients with stage II-IA/IIIB non-small cell lung cancer were treated with helical tomotherapy at the S. Camillo-Forlanini Hospital. For our study we selected 20 patients who underwent chemotherapy followed by sequential radiotherapy. The planning target volume was delineated using planning CT scan and FDG-PET. The mean prescribed radiation dose was 67.5 Gy delivered in 30 fractions at a dose of 2.25 Gy per fraction. Results. Median follow-up was 12.3 months. All patients developed acute esophageal toxicity, 15 of RTOG grade 1 and 5 of RTOG grade 2. At first follow-up 15 patients presented stable disease or partial response, 4 patients presented complete response, and 1 patient presented disease progression. Conclusions. Helical tomotherapy is useful to achieve dose-per-fraction escalation without increasing the treatment-related morbidity. Our results applying dose escalation were encouraging considering that we delivered doses that may be difficult to achieve with 3-dimensional treatments with no excessive complication rates

    Deep learning method for tomotherapy delivery quality assurance: prediction of three-dimensional dose distribution and performance evaluation on phantom

    No full text
    High-tech radiotherapy capable to provide complex dose delivery modalities is one of the most important treatment modalities for cancer patients, making essential to evaluate with accuracy the clinical machine performances and the quality of the treatment plans [1–3]. The operation of Delivery Quality Assurance (DQA) is repetitive and involving both workforce and Linac bunker occupational time. To work around this problem, we developed new deep neural network models capable of predicting passing rates a priori for Helical Tomotherapy (HT) DQA in 3D voxel-by-voxel dose prediction. In this paper we evaluated net performances, focusing on learning quality in function of specific machine parameters

    Deep learning method for TomoTherapy Hi-Art: prediction three‐dimensional dose distribution

    No full text
    Purpose or Objective High-tech radiotherapy capable to provide complex dose delivery modalities is one of the most important treatment modalities for cancer patients, making essential to evaluate with accuracy the clinical machine performances and the quality of the treatment plans [1-3]. The operation of Delivery Quality Assurance (DQA) is repetitive and involving both workforce and Linac bunker occupational time. To work around this problem, we developed new deep neural network models capable of predicting passing rates a priori for Helical Tomotherapy (HT) DQA in 3D voxel-by-voxel dose prediction. In this paper we evaluated net performances, focusing on learning quality in function of specific machine parameters
    corecore